Vera Therapeutics, Inc. ( VERA) - Stock Earnings
VERA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -80.3 million USD | — USD |
| 2025Q4 | -91.1 million USD | — USD |
| 2026Q1 | -121.0 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VERA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -96.0 million USD | 1.9 million USD |
| 2024 | -152.1 million USD | — USD |
| 2025 | -299.6 million USD | — USD |
| 2026 Est. | — | — |
VERA
Price: $34.24
52 week price:
Earnings Per Share: -5.54 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 367897
Market Capitalization: 2.2 billion